Abstract
AbstractA sensitive and selective hydrophilic interaction liquid chromatography-tandem mass spectrometry (HILIC-MS/MS) method was developed and validated for trace analysis of potential genotoxic impurities (PGIs): 2,3-dichloroaniline (PGI-1), bis(2-chloroethyl) amine (PGI-2), and 2-chloroethylamine (PGI-3), in aripiprazole (APZ) active drug substance. Separation of analytes was achieved on ACE HILIC–N Column (HILN-5-1046U, 100 × 4.6 mm, 5 μm) in gradient elution mode with mobile phase A [acetonitrile:ammonium formate buffer (95:5 v/v)] and mobile phase B [acetonitrile:ammonium formate buffer (50:50 v/v)] at a flow rate of 0.8 mL/min. Developed method was linear in the concentration range of 8–100 ppm for PGI-1, 11–100 ppm for PGI-2, and 12.5–100ppm for PGI-3 with R2 > 0.996. The developed method was accurate for quantification of each PGI with percent recoveries greater than 96% and RSD (%) not more than 5%. The developed method was precise for quantification of PGIs in aripiprazole with RSD (%) of not more than 4% for any of the PGIs. There was no interference of diluent peaks at the retention time of the PGIs and APZ in the method. All the PGIs and sample solutions were found to be stable at ambient laboratory temperature (25 ± 5 °C) and refrigerated condition (2–8 °C) for a period of 48 h. The developed HILIC-MS/MS method can be used for trace quantification of PGIs in aripiprazole drug in quality control laboratories of the pharmaceutical industry.
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Environmental Science,General Biochemistry, Genetics and Molecular Biology,General Materials Science,General Chemistry
Reference22 articles.
1. Ambavaram VB, Nandigam V, Vemula M, Kalluru GR, Gajulapalle M. Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of urapidil and aripiprazole in human plasma and its application to human pharmacokinetic study. Biomed. Chromatogr. 2013;27(7):916–23. https://doi.org/10.1002/bmc.2882.
2. Caloro M, Lionetto L, Cuomo I, Simonetti A, Pucci D, De Persis S, et al. An improved simple LC-MS/MS method for the measurement of serum aripiprazole and its major metabolite. J. Pharm. Biomed. Anal. 2012;62:135–9. https://doi.org/10.1016/j.jpba.2012.01.003.
3. Djordjevic Filijovic N, Pavlovic A, Nikolic K, Agbaba D. Validation of an HPLC method for determination of aripiprazole and its impurities in pharmaceuticals. Acta. Chromatogr. 2014;26(1):13–28. https://doi.org/10.1556/AChrom.26.2014.1.15.
4. International Council for Harmonization, .n.d.-a, M7 guideline: assessment and control of DNA reactive (Mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk. https://database.ich.org/sites/default/files/M7_R1_Guideline.pdf
5. International Council for Harmonization, n.d.-b, Q3A (R2) guideline: impurities in new drug substances. https://database.ich.org/sites/default/files/Q3A_R2 Guideline.pdf
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献